Trial Profile
0.1%Tacrolimus (FK506) in the treatment of sjogren's syndrome clinical efficacy evaluation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Hyaluronic acid
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 28 Apr 2016 New trial record